RecruitingPhase 4NCT06465641

Methylphenidate in KBG Syndrome: N-of-1 Series

Studying KBG syndrome

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Radboud University Medical Center
Intervention: Methylphenidate Hydrochloride(drug)
Enrollment: 15 enrolled
Eligibility: 6-20 years · All sexes
Timeline: 2024 – 2027

Study locations (1)

Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06465641 on ClinicalTrials.gov

← Back to all trials